Helixon

China
Caoxi, Jiangxi, China

Company profile

Helixon company profile

Huashen Zhiyao is a biotechnology company that accelerates novel drug discovery for unmet medical needs. Huashen Zhiyao develops an AI drug development platform and antibody engineering experiment platform to provide researchers with intelligent systems for microscopic molecular calculation, simulation, and design, committing to improving the speed and efficiency of new drug development.

Business identity

Contact email
[email protected].
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2021-07-01, Month

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$84.6M
Last funding
Series A / $74.6M / 2022-06-22
Last equity funding
Series A / $74.6M
Investors
6
Lead investors
2
Articles
6

Founders and investors

Lead investors

Wuyuan CapitalXianghe Capital

Investors

Gaorong CapitalHillhouse InvestmentQingzhi CapitalWuyuan CapitalXianghe Capital